Unknown

Dataset Information

DNA-PKcs Inhibition Extends Allogeneic Skin Graft Survival.


ABSTRACT:

Background

Organ transplantation is life-saving and continued investigations into immunologic mechanisms that drive organ rejection are needed to improve immunosuppression therapies and prevent graft failure. DNA-dependent protein kinase catalytic subunit, DNA dependent-protein kinase catalytic subunit (DNA-PKcs), is a critical component of both the cellular and humoral immune responses. In this study, we investigate the contribution of DNA-PKcs to allogeneic skin graft rejection to potentially highlight a novel strategy for inhibiting transplant rejection.

Methods

Fully MHC mismatched murine allogeneic skin graft studies were performed by transplanting skin from BalbC mice to C57bl6 mice and treating with either vehicle or the DNA-PKcs inhibitor NU7441. Graft rejection, cyt

SUBMITTER: Harrison DK 

PROVIDER: S-EPMC7902289 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature